CLINICAL SUPPLY REGULATORY ARTICLES
![4 Tips For Successful Collaboration With Your EU Qualified Person Fist-Bump-iStock-1133580260](https://vertassets.blob.core.windows.net/image/c11f36c0/c11f36c0-d3fa-46c3-bba9-626c3503c8fc/510_340-fist_bump_istock_1133580260.png)
Engaging QPs well before the clinical trial material needs to be certified not only assures a smooth release process and trial start-up but mitigates pitfalls associated with unanticipated challenges.
CLINICAL SUPPLY REGULATORY RESOURCES
-
Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing essential support and resources that empower it to thrive in its objectives and endeavors.
-
Start leveraging logistics partners with global end-to-end solutions that can help avoid costly delays, ensure high product quality, and accelerate impactful solutions for patients worldwide.
-
See how teams ensured a seamless route, including on-time customs clearance and delivery of autologous cell therapy, from the U.S. to a manufacturing site in Germany
-
Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
Learn how the CRO ClinChoice and the sponsor 89Bio were conducting a phase II, randomized, double-blind, placebo-controlled study that needed to pivot to a decentralized protocol during the pandemic or face trial disruption.
-
Assessing outsourcing partners’ credentials in people, technology, supply chains, and integration will make all the difference as sponsors aim to streamline processes on the path to commercialization.
-
Learn how by having a strategy for “core-to-carton” compliance, drug developers can avoid risks for patients and their company.